Literature DB >> 16409721

[A study of pulmonary inflammatory reaction induced by N-protein of SARS-CoV in rat models and effects of glucocorticoids on it].

Dong Hao1, Li-xian He, Jie-ming Qu, Jue Pan, Bi-jie Hu, Jing Zhang, Zhuo-zhe Li.   

Abstract

OBJECTIVE: To study the pulmonary inflammatory reaction induced by N-protein of SARS-CoV in rat models and the effects of glucocorticoids on the inflammatory reaction.
METHODS: The pulmonary inflammatory reaction in rat models were induced by intratracheal instillation of N-protein of SARS-CoV with a dose of 0.2 mg/kg. The rats were randomly divided into four groups: normal saline control group (Nc group), N-protein group 1 (P1 group, 6 h), N-protein group 2 (P2 group, 24 h), and N-protein + dexamethasone group (P + D group, dexamethasone 10 mg/kg intraperitoneally). The blood samples, bronchial alveolar lavage fluid (BALF) and lung tissue were collected after challenge. The cytological and histopathologic changes of lung tissues were observed and the wet/dry ratios (W/D) of lung tissue were determined. The interleukin (IL)-6, IL-10 and transforming growth factor-beta1 (TGF-beta1) of serum and BALF were measured by ELISA.
RESULTS: (1) Compared with the percentage of peripheral blood lymphocytes in Nc group [(68.42 +/- 13.07)%], that in P2 group [(50.50 +/- 14.36)%] was significantly decreased (P < 0.05); compared with Nc group and P2 group, that in P + D group was furthermore significantly decreased (P < 0.01). Compared with the total WBC of peripheral blood in Nc group [(5.86 +/- 2.25) x 10(9)] and P2 group [(4.83 +/- 1.49) x 10(9)], that in P + D group [(1.96 +/- 1.30) x 10(9)] was significantly decreased (P < 0.01). (2) Compared with the total WBC of BALF in Nc group [(95 +/- 29) x 10(7)], that in P2 group [(160 +/- 60) x 10(7)] was significantly increased (P < 0.05); but compared with P2 group, that in P + D group [(62 +/- 23) x 10(7)] was significantly decreased (P < 0.05). Analysis of BALF differential cell counts showed that the majority of cells were alveolar macrophages in all groups. (3) The W/D ratios of lung tissue in both P1 and P2 group [(5.18 +/- 0.29) and (5.19 +/- 0.34), respectively] after N-protein challenge were significantly increased than that in Nc groups [(4.77 +/- 0.27), P < 0.05]; the W/D ratio in P + D group (4.70 +/- 0.18) was significantly decreased than that in P2 group (P < 0.01). (4) Compared with Nc group, the levels of IL-6, IL-10, TGF-beta1 in both serum and BALF of P1 group were significantly increased (P < 0.01), and the levels of these cytokines in P2 group were significantly higher than those in P1 group (P < 0.01), but significantly lower in P + D group compared with P2 group (P < 0.01).
CONCLUSIONS: The N-protein of SARS-CoV had pathogenicity and could induce obvious pulmonary inflammatory reaction and acute lung injury, which were related to the increase and imbalance of pro-inflammatory and anti-inflammatory cytokines. Glucocorticoids could effectively alleviate the pulmonary inflammatory reaction induced by N-protein of SARS-CoV.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16409721

Source DB:  PubMed          Journal:  Zhonghua Nei Ke Za Zhi        ISSN: 0578-1426


  9 in total

Review 1.  Virus Caused Imbalance of Type I IFN Responses and Inflammation in COVID-19.

Authors:  Jintao Zhang; Chunyuan Zhao; Wei Zhao
Journal:  Front Immunol       Date:  2021-04-12       Impact factor: 7.561

2.  Effects of Short-Term Low-Dose Glucocorticoids for Patients with Mild COVID-19.

Authors:  Hai-Yan Fu; Yu Luo; Jian-Peng Gao; Lin Wang; Hong-Juan Li; Xiang Li; Lian Xue; Xiao-Qing Tang; Hai-Wen Li; Ying-Rong Du
Journal:  Biomed Res Int       Date:  2020-09-23       Impact factor: 3.411

Review 3.  The role of C5a in acute lung injury induced by highly pathogenic viral infections.

Authors:  Renxi Wang; He Xiao; Renfeng Guo; Yan Li; Beifen Shen
Journal:  Emerg Microbes Infect       Date:  2015-05-06       Impact factor: 7.163

Review 4.  Associations between immune-suppressive and stimulating drugs and novel COVID-19-a systematic review of current evidence.

Authors:  Beth Russell; Charlotte Moss; Gincy George; Aida Santaolalla; Andrew Cope; Sophie Papa; Mieke Van Hemelrijck
Journal:  Ecancermedicalscience       Date:  2020-03-27

5.  [Dynamic inflammatory response in a critically ill COVID-19 patient treated with corticosteroids].

Authors:  Sheng Zhagn; Danping Li; Huazhong Chen; Dan Zheng; Yiping Zhou; Baoguo Chen; Weiwu Shi; Ronghai Lin
Journal:  Zhejiang Da Xue Xue Bao Yi Xue Ban       Date:  2020-05-25

Review 6.  Seven recommendations to rescue the patients and reduce the mortality from COVID-19 infection: An immunological point of view.

Authors:  Andreas Kronbichler; Maria Effenberger; Michael Eisenhut; Keum Hwa Lee; Jae Il Shin
Journal:  Autoimmun Rev       Date:  2020-05-03       Impact factor: 9.754

7.  Boosted expression of the SARS-CoV nucleocapsid protein in tobacco and its immunogenicity in mice.

Authors:  Nuoyan Zheng; Ran Xia; Cuiping Yang; Bojiao Yin; Yin Li; Chengguo Duan; Liming Liang; Huishan Guo; Qi Xie
Journal:  Vaccine       Date:  2009-06-11       Impact factor: 3.641

Review 8.  Exercise, nutrition, and medication considerations in the light of the COVID pandemic, with specific focus on geriatric population: A literature review.

Authors:  Yi-Chiang Yang; Cheng-Liang Chou; Chung-Lan Kao
Journal:  J Chin Med Assoc       Date:  2020-11       Impact factor: 2.743

Review 9.  MS, pregnancy and COVID-19.

Authors:  Charmaine Yam; Vilija Jokubaitis; Kerstin Hellwig; Ruth Dobson
Journal:  Mult Scler       Date:  2020-08-17       Impact factor: 6.312

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.